A corporate sustainability pledge and a genuinely sustainable product are not automatically the same thing. Medical device manufacturers increasingly publish ambitious climate targets, and many back those targets with real capital investment and measurable progress, but evaluating which commitments translate into verified environmental performance requires looking past the headline pledge toward the specific evidence a company actually publishes.
The scale of what is at stake is not trivial: the World Health Organization has estimated that healthcare overall contributes roughly 5 percent of global greenhouse gas emissions, and separate analysis has found that a substantial majority of that footprint, often cited around 70 percent, traces back to the healthcare supply chain, meaning the manufacturing, packaging, transportation, and disposal of the devices and supplies hospitals purchase, rather than the energy hospitals burn directly on-site.
The medical technology sector overall has made real, if uneven, progress on this front. Industry analysis has found that the substantial majority of leading medtech companies have set carbon reduction targets, though a notably smaller share have extended those targets to include supplier and customer emissions, the so-called scope 3 emissions that often represent the largest share, sometimes estimated at 80 percent or more for manufacturing companies broadly, of a company’s total environmental footprint.
How the Manufacturers Were Evaluated
This comparison prioritizes companies with publicly documented carbon reduction targets, evidence of product-level lifecycle consideration, transparent sustainability reporting, and demonstrated progress rather than aspiration alone. Renewable energy adoption in manufacturing operations, packaging and waste reduction initiatives, circular economy programs such as device reprocessing, and the scope of emissions targets, meaning whether they extend beyond a company’s own operations into its supply chain, all factored into which companies are profiled below.
Top Sustainable Medical Device Manufacturers
Medtronic
Medtronic has set an ambition to reach net zero emissions across its full value chain, spanning direct operations and its broader supply and distribution network, by 2045. The company has pursued this goal through measures including cogeneration systems at manufacturing facilities that substantially reduce reliance on grid electricity, LEED-certified manufacturing facilities including a platinum-certified site in Costa Rica, and a supplier engagement program that rewards vendors for measurable greenhouse gas reduction across Medtronic’s supply chain, an approach directly targeting the scope 3 emissions category that dominates most manufacturers’ total footprint.
Philips
Philips has positioned environmental technology as a core part of its healthcare business strategy, targeting carbon neutrality alongside a goal of sourcing 75 percent renewable energy across its operations. The company has also committed to reducing emissions across its full value chain in alignment with global climate targets aimed at limiting warming to 1.5 degrees Celsius, extending its sustainability commitments beyond its own direct operations into its broader supply chain.
Boston Scientific
Boston Scientific was among the earlier medical device manufacturers to commit to carbon neutrality specifically across its manufacturing and key distribution sites, targeting this goal by 2030. The company has pursued this through industry collaboration aimed at reducing waste, cutting energy consumption, and expanding recycling opportunities, applying a structured process to prioritize and monitor sustainability efforts across its global manufacturing and supply chain footprint.
Terumo Corporation
Terumo Corporation is a major Japanese medical device manufacturer that has built sustainability into its core operational priorities, targeting greenhouse gas emission reduction, waste minimization, and efficient resource use across its manufacturing footprint. The company has placed particular emphasis on water usage considerations in its production processes, a meaningful focus given the water-intensive nature of much medical device and pharmaceutical manufacturing amid growing global water scarcity concerns.
Zimmer Biomet
Zimmer Biomet has emphasized energy efficiency and waste reduction within its manufacturing processes, alongside responsible sourcing initiatives aimed at reducing the environmental impact of its supply chain. The company has also incorporated sustainability considerations into product design itself, aiming to improve device longevity and recyclability as part of its broader environmental strategy.
Stryker
Stryker has built out dedicated sustainability solutions focused on device reprocessing, a circular economy approach that extends the useful life of eligible medical devices rather than treating every use as requiring a new, single-use product. In 2023, the company’s reprocessing programs enabled customers to divert more than 5 million pounds of waste from landfills, illustrating how circular economy approaches can deliver measurable environmental benefit at meaningful scale within existing clinical workflows, a figure roughly equivalent to the weight of several hundred full-size passenger vehicles diverted from disposal in a single year.
GE HealthCare
GE HealthCare has set carbon reduction targets alongside other major medical technology companies, reflecting the broader industry shift toward formalized climate commitments among the largest sector participants. As a major manufacturer of large capital equipment like imaging systems, which can run continuously and represent some of the more energy-intensive equipment categories in a typical hospital, the company’s energy efficiency initiatives in product design carry particular relevance given how much this equipment contributes to a healthcare facility’s overall energy footprint.
Siemens Healthineers
Siemens Healthineers has similarly established carbon reduction commitments as part of the broader medtech industry trend toward climate target setting. Its focus on large diagnostic and imaging equipment gives energy efficiency improvements in product design a meaningful role in its overall sustainability approach, given how significantly this equipment category contributes to a hospital’s total energy consumption.
Johnson & Johnson MedTech
Johnson & Johnson MedTech, as part of one of the largest healthcare companies globally, with total company revenue running into the tens of billions of dollars annually, has integrated sustainability commitments across its broader corporate structure, extending into its medical device business alongside its pharmaceutical and consumer health operations. This scale gives the company’s supply chain sustainability requirements the potential to influence practices across a very broad base of suppliers and partners within the medical device manufacturing ecosystem.
The Difference Between Corporate Sustainability and Sustainable Products
A company-wide carbon reduction target, however ambitious, does not automatically mean every individual product that company manufactures is itself more environmentally sustainable than a competitor’s equivalent product. Corporate sustainability commitments typically address manufacturing operations, facility energy use and supply chain emissions in aggregate, while product-level sustainability depends on specific design choices, material selection and lifecycle considerations made for that particular device.
A hospital procurement team evaluating a specific product should look for product-level evidence, such as material composition, packaging design and end-of-life pathway, rather than assuming a company’s broader sustainability commitments automatically apply uniformly across its entire product portfolio. The most transparent manufacturers increasingly provide this product-level detail directly, recognizing that aggregate corporate commitments alone no longer satisfy increasingly sophisticated healthcare procurement sustainability requirements.
The Technologies Driving Greener Medical Devices
Several specific technology and design approaches are driving genuine sustainability improvement across the medical device sector. Energy-efficient device design, particularly for large capital equipment like imaging systems that run continuously in clinical settings, reduces a device’s operational carbon footprint over its service life. Reusable system design, where clinically appropriate, reduces the continuous manufacturing and waste stream associated with single-use alternatives.
Digital monitoring and remote diagnostic capability can reduce transportation-related emissions by decreasing the need for in-person visits for certain monitoring functions. Material reduction in both devices and packaging lowers the resource footprint per unit produced. Refurbishment and reprocessing programs, exemplified by initiatives like Stryker’s multi-million-pound annual landfill diversion, extend device service life and divert substantial waste from landfills. Remote diagnostics for equipment maintenance can also reduce unnecessary service visits and premature equipment replacement, extending useful device lifespan through more precisely targeted maintenance.
How Hospitals Should Evaluate Sustainability Claims
Healthcare procurement teams evaluating manufacturer sustainability claims benefit from asking for specific lifecycle evidence rather than accepting general marketing language at face value. Requesting product-level documentation, including material composition and end-of-life recyclability information, provides a more concrete basis for comparison than a manufacturer’s corporate sustainability report alone. Comparing total lifecycle impact, accounting for manufacturing, packaging, use-phase energy consumption, and disposal, offers a more complete picture than any single stage evaluated in isolation.
Clinical safety must remain the non-negotiable foundation of any procurement decision, meaning sustainability considerations should inform choices among clinically equivalent options rather than ever taking priority over patient safety and clinical performance requirements. Independent verification, where available through recognized environmental certifications or third-party audits, provides more reliable assurance than self-reported manufacturer claims alone.
Where the Industry Still Has Difficult Tradeoffs
The medical device industry continues to navigate genuine, unresolved tensions between environmental goals and other essential priorities. Sterility and infection prevention requirements often favor single-use devices in specific clinical contexts, creating an unavoidable tension with waste reduction goals that no amount of manufacturing innovation can fully eliminate for certain product categories. The continued clinical necessity of many single-use devices, despite their environmental footprint, means blanket criticism of this product category oversimplifies a genuinely complex clinical and environmental tradeoff.
Supply chain resilience considerations, particularly following recent years of well-documented medical supply disruptions, can sometimes conflict with sustainability goals like minimizing transportation distances or reducing supplier diversification. Electronic waste from increasingly connected medical devices presents a growing challenge that traditional device disposal frameworks were not originally designed to address. Cost considerations remain a persistent factor as well, since more sustainable materials or manufacturing processes sometimes carry a cost premium that healthcare organizations operating under tight margins must weigh carefully against other competing budget priorities.
The World Health Organization has noted that healthcare overall contributes a meaningful share of global greenhouse gas emissions, with a substantial portion of that footprint, an estimated 70 percent by some accounts, associated with the healthcare supply chain rather than direct clinical operations, reinforcing why manufacturer-level sustainability commitments, and the procurement decisions of the hospitals and health systems that purchase their products, both matter significantly to the sector’s overall environmental trajectory.
Evaluating sustainable medical device manufacturers requires looking past headline commitments toward verified, product-level evidence and genuine progress against stated targets over time. The manufacturers profiled here have each taken meaningful, documented steps toward reducing their environmental footprint, from Stryker’s multi-million-pound annual reprocessing diversion to Medtronic’s 2045 value chain net zero target, though healthcare procurement teams should continue pressing for the kind of specific, product-level transparency that allows genuinely informed purchasing decisions rather than relying on corporate reputation alone.
This article provides general information about medical device manufacturer sustainability programs based on publicly available information and does not constitute an endorsement of any specific company or product. Sustainability commitments and progress should be verified directly with manufacturers, as targets and achievements change over time.
FAQ
Q: What is a sustainable medical device?
A: A sustainable medical device minimizes environmental impact across its lifecycle, including material sourcing, manufacturing, packaging, energy use during operation, and end-of-life disposal or recycling, while still meeting all clinical safety requirements.
Q: Which medical device manufacturers have sustainability programs?
A: Major manufacturers with documented sustainability commitments include Medtronic, Philips, Boston Scientific, Becton Dickinson, Terumo, Zimmer Biomet, Stryker, GE HealthCare, Siemens Healthineers, and Johnson & Johnson MedTech.
Q: How are medical device companies reducing emissions?
A: Common approaches include renewable energy adoption in manufacturing, energy-efficient device design, packaging reduction, device reprocessing and refurbishment programs, and supplier engagement on emissions reduction, targeting the scope 3 supply chain emissions that often dominate a manufacturer’s total footprint.
Q: What should hospitals ask suppliers about sustainability?
A: Hospitals should ask for specific product-level lifecycle evidence, material composition data, end-of-life disposal or recycling pathways, and independent verification where available, rather than relying on general corporate marketing claims.
Q: Are sustainable medical devices more expensive?
A: Sometimes, though not universally. More sustainable materials or manufacturing processes can carry a cost premium in some cases, while other sustainability improvements, like device reprocessing programs, can actually reduce costs.
Q: Does a company’s carbon reduction target apply to every product it makes?
A: Not necessarily. Corporate sustainability commitments typically address aggregate operations and supply chain emissions, which does not automatically mean every individual product is equally sustainable compared to competitors.
Q: What is device reprocessing?
A: Device reprocessing involves cleaning, testing and reusing certain eligible medical devices originally designed for single use, extending their service life and reducing landfill waste when done in accordance with regulatory requirements. Stryker’s program alone diverted more than 5 million pounds of waste in 2023.
Q: Can single-use medical devices ever be considered sustainable?
A: Single-use devices remain clinically necessary in many contexts for infection prevention, and manufacturers can still pursue sustainability through material selection, packaging reduction, and end-of-life recycling pathways, even without eliminating single-use design entirely.